港股異動丨喆麗控股飆升逾22%創歷史新高,料上半年純利同比增約6.1倍
喆麗控股YesAsia Holdings(2209.HK)發盈喜,盤初一度飆升22.73%至5.4港元,創歷史新高,市值升至21.6億港元。公司昨晚公佈,預期截至6月底止中期綜合純利不少於1110萬美元,同比增加約6.1倍,主要是由於收益及毛利增加;去年同期淨溢利約156.3萬美元。期內,綜合收益預計約1.63億美元,同比上升80.2%,主要是受YesStyle平台及AsianBeautyWholesale的美容產品銷售增長所推動。毛利率預計將小幅下降約0.4個百分點至約30.7%,主要是由於AsianBeautyWholesale的收益比重增加。綜合毛利預計約5015.3萬美元,同比增加約78%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.